| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/1997 | US5631241 Wound healing agents of high molecular weight for eyes as antiinflammatory agents |
| 05/20/1997 | US5631238 Anticarcinogenic agents |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631235 Immunosuppressants, antiarthritics and autoimmune diseases |
| 05/20/1997 | US5631234 Method for treating ischemia-reperfusion tissue injury |
| 05/20/1997 | US5631224 Use of a peptide |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5631023 Method for making freeze dried drug dosage forms |
| 05/20/1997 | US5631022 Picosulfate dosage form |
| 05/20/1997 | US5631017 Topical application of buspirone for treatment of pathological conditions associated with immune responses |
| 05/20/1997 | US5631011 Hyaluronic acid or derivative; wound healing agents |
| 05/20/1997 | US5631005 Preservatives for contact lens solutions |
| 05/20/1997 | US5631004 Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
| 05/20/1997 | US5630999 Oral composition containing anionic surfactants having reduced adverse reaction to oral tissue |
| 05/20/1997 | CA2112355C Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 05/20/1997 | CA2091172C Antiviral compounds and antihypertensive compounds |
| 05/20/1997 | CA2073340C Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| 05/20/1997 | CA2064704C Onset-hastened/enhanced antipyretic response |
| 05/20/1997 | CA2044515C Cyclic amide derivatives |
| 05/20/1997 | CA2019841C 4,5-dihydro-6h-imidazo[4,5,1-ij]quinolin-6-one-6- oxime-o-sulfonic acid derivatives |
| 05/18/1997 | CA2188485A1 Piperidinylethylamide derivatives as serotonergic agents |
| 05/18/1997 | CA2188484A1 Piperazinyl benzamide derivatives as serotonergic agents |
| 05/18/1997 | CA2163163A1 Low-irritation anesthetic and antiseptic mouth rinse |
| 05/16/1997 | CA2189097A1 Composition and method of treating retroviral infection |
| 05/15/1997 | WO1997017612A1 Prevention of sudden infant death |
| 05/15/1997 | WO1997017449A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017434A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 05/15/1997 | WO1997017433A1 Tissue-specific and target rna-specific ribozymes |
| 05/15/1997 | WO1997017365A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 05/15/1997 | WO1997017364A1 Peptide derivatives of dolastatin 15 and their use |
| 05/15/1997 | WO1997017363A1 Thrombin inhibitors |
| 05/15/1997 | WO1997017362A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds |
| 05/15/1997 | WO1997017357A1 3-deoxy-3-descladinose derivatives of erythromycins a and b |
| 05/15/1997 | WO1997017356A1 Tricyclic erythromycin derivatives |
| 05/15/1997 | WO1997017351A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 05/15/1997 | WO1997017350A1 Azaspiro derivatives with 5ht1b activity |
| 05/15/1997 | WO1997017348A1 1-azabicycloheptane derivatives and their pharmaceutical use |
| 05/15/1997 | WO1997017347A1 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof |
| 05/15/1997 | WO1997017346A1 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof |
| 05/15/1997 | WO1997017345A1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands |
| 05/15/1997 | WO1997017344A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 05/15/1997 | WO1997017343A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 05/15/1997 | WO1997017342A1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 05/15/1997 | WO1997017341A1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 05/15/1997 | WO1997017340A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 05/15/1997 | WO1997017339A1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 05/15/1997 | WO1997017333A1 Benzoxazine antimicrobial agents |
| 05/15/1997 | WO1997017332A1 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation |
| 05/15/1997 | WO1997017330A1 Process |
| 05/15/1997 | WO1997017326A1 Enantiomers of cis-benz[e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 05/15/1997 | WO1997017325A1 Derivates of n,n-dimethyl-2-(arylthio)benzylamine, their salts, methods of preparation and their use in pharmaceutical medicaments |
| 05/15/1997 | WO1997017317A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017316A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017085A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017083A1 Method for treating obesity and type ii diabetes by adjusting the circadian rhythm of human growth hormone |
| 05/15/1997 | WO1997017081A1 Use of d-arginine and/or l-arginine to remove or block toxic carbonyls and/or dicarbonyls |
| 05/15/1997 | WO1997017080A1 Germanium yeast human diet nutritional supplement |
| 05/15/1997 | WO1997017078A1 Use of polyethylene glycol for the prevention or treatment of diseases of the mucous membranes |
| 05/15/1997 | WO1997017077A1 Topical composition containing capsazepine |
| 05/15/1997 | WO1997017075A1 Topical foamable pharmaceutical composition for treating skin diseases induced by oval pityrosporum |
| 05/15/1997 | WO1997017074A1 Treatment of traumatic brain injury |
| 05/15/1997 | WO1997017073A1 A method of treating filariae |
| 05/15/1997 | WO1997017072A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 05/15/1997 | WO1997017070A1 Inhibitors of protein isoprenyl transferases |
| 05/15/1997 | WO1997017069A1 Methods for treating resistant tumors |
| 05/15/1997 | WO1997017068A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | WO1997017063A1 Microencapsulated dna for vaccination and gene therapy |
| 05/15/1997 | WO1997017061A1 Therapeutic preparation for the transdermal administration of active substances |
| 05/15/1997 | WO1997016983A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997011668A3 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 05/15/1997 | WO1997011093A3 Parainfluenza virus glycoproteins and vaccines |
| 05/15/1997 | WO1997010332A3 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 05/15/1997 | DE19542281A1 Verwendung von Epinastin für die Behandlung von Schmerzen Use of epinastine in the treatment of pain |
| 05/15/1997 | DE19541919A1 Compositions containing a pantothenol derivative and a sympathomimeticum |
| 05/15/1997 | DE19541815A1 Verwendung von Polyethylenglykol zur Prävention oder Behandlung von Erkrankungen der Schleimhäute Use of polyethylene glycol for the prevention or treatment of diseases of the mucous membranes |
| 05/15/1997 | DE19541405A1 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen Use of flupirtine for the prophylaxis and therapy of diseases which are associated with impairment of the hematopoietic cell system |
| 05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
| 05/15/1997 | CA2236928A1 Benzoxazine antimicrobial agents |
| 05/15/1997 | CA2236923A1 Use of d-arginine and/or l-arginine to remove or block toxic carbonyls and/or dicarbonyls |
| 05/15/1997 | CA2236836A1 1-azabicycloheptane derivatives and their pharmaceutical use |
| 05/15/1997 | CA2236678A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 05/15/1997 | CA2236543A1 Methods for treating resistant tumors |
| 05/15/1997 | CA2236450A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | CA2235824A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 05/15/1997 | CA2235681A1 3-deoxy-3-descladinose derivatives of erythromycins a and b |
| 05/15/1997 | CA2235586A1 Thrombin inhibitors |
| 05/15/1997 | CA2235416A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | CA2235347A1 In vitro construction of sv40 viruses and pseudoviruses |
| 05/15/1997 | CA2235301A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 05/15/1997 | CA2234824A1 Treatment of traumatic brain injury |
| 05/15/1997 | CA2234797A1 Topical composition containing capsazepine |
| 05/15/1997 | CA2234683A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | CA2209484A1 Germanium yeast human diet nutritional supplement |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773226A1 Propiophenone derivative and processes for preparing the same |
| 05/14/1997 | EP0773223A1 Tetracyclic 1,4-oxazine compounds, process for their preparation and pharmaceutical compositions containing them |